1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Interleukin 4 promotes phagocytosis of murine leukemia cells counteracted by CD47 upregulation
(
- Contribution to journal › Article
-
Mark
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
2022) In Blood Advances(
- Contribution to journal › Article
- 2021
-
Mark
Sister chromatid cohesion defects are associated with chromosomal copy number heterogeneity in high hyperdiploid childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 2020
-
Mark
CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia
(
- Contribution to journal › Article
-
Mark
Clonal competition within complex evolutionary hierarchies shapes AML over time
(
- Contribution to journal › Article
- 2019
-
Mark
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells
(
- Contribution to journal › Article
- 2018
-
Mark
Studies of Ligands and Receptors Regulating Acute Myeloid Leukemia
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6 dependent manner
(
- Contribution to journal › Article
- 2017
-
Mark
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells
(
- Contribution to journal › Article
- 2014
-
Mark
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
(
- Contribution to journal › Article